Skip to main content
. 2013 May 14;13:85. doi: 10.1186/1471-230X-13-85

Table 2.

The Los Angeles classification and Lanza scores at baseline and after treatment

  Baseline Post-treatment p value1
Irsogladine group
 
 
 
Los Angeles classification
Grade O (16/16)
Grade O (16/16)
 
Lanza scores (stomach) (mean ± SD)
0.5 ± 1.1
0.9 ± 1.0
NS
Lanza scores (duodenum) (mean ± SD)
0.0 ± 0.0
0.4 ± 0.9
NS
Omeprazole group
 
 
NS
Los Angeles classification
Grade O (16/16)
Grade O (16/16)
 
Lanza scores (stomach) (mean ± SD)
0.6 ± 0.9
1.5 ± 1.1
NS
Lanza scores (duodenum) (mean ± SD) 0.0 ± 0.0 0.4 ± 0.8 0.0049

1P-values are baseline versus post-treatment within groups.